Actively Recruiting

Phase Not Applicable
Age: 20Years +
All Genders
NCT06878391

ISB With SSNB & ANB

Led by Chuncheon Sacred Heart Hospital · Updated on 2025-05-29

100

Participants Needed

2

Research Sites

96 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study is a prospective, randomized, double-blind trial comparing patients who underwent arthroscopic rotator cuff repair and received an interscalene brachial plexus block (9 ml of 0.75% ropivacaine, 3 ml for each trunk) combined with suprascapular nerve block and axillary nerve block (each with 10 ml of 0.75% ropivacaine) versus those who received an interscalene brachial plexus block (9 ml of 0.75% ropivacaine, 3 ml for each trunk) combined with placebo suprascapular and axillary nerve blocks (each with 10 ml of 0.9% saline). The study will compare subjective pain scores (VAS score) and patient satisfaction preoperatively and at 1, 3, 6, 12, 18, 24, 36, and 48 hours postoperatively. Additionally, 5 ml of venous blood will be collected preoperatively and at 1, 6, 12, 24, and 48 hours postoperatively to analyze and compare serum levels of cortisol, IL-6, IL-8, IL-1β, substance P, serotonin, β-endorphin, and norepinephrine.

CONDITIONS

Official Title

ISB With SSNB & ANB

Who Can Participate

Age: 20Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • a definite rotator cuff tear that needed repair seen on preoperative magnetic resonancce imaging (MRI)
  • acceptance of arthroscopic surgery including rotator cuff repair
  • age same as or more than 20 years
  • acceptance of preemptive regional block and PCA, and blood testing
Not Eligible

You will not qualify if you...

  • did not undergo arthroscopic rotator cuff repair
  • stopped PCA before 48 hours postoperatively because of associated side effects
  • a history of previous ipsilateral shoulder operation or fracture
  • a concomitant neurologic disorder around the shoulder
  • a failure of blood sampling including hemolysis, etc.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Hallym University Chuncheon Sacred Heart Hospital

Chuncheon, Gangwon-do, South Korea, 24253

Not Yet Recruiting

2

Hallym University Chuncheon Sacred Heart Hospital

Chuncheon, Gangwon-do, South Korea, 24253

Actively Recruiting

Loading map...

Research Team

J

Jung-Taek Hwang, MD, PhD

CONTACT

S

Su-Jung Seo, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here